Glanbia in line with growth forecasts

Glanbia is on course to deliver on its 7%-10% growth forecast for 2017, with revenues for the year to September 6.6% higher than this time last year.

The global nutrition group’s nine-month interim management statement reports this performance was driven by volume growth of 2.4%, pricing growth of 0.9%, and a contribution from acquisitions of 3.3%. Total group revenue increased 13.5% on a reported basis and 13.7% on a constant currency basis. This was driven by 2.3% volume growth, 6.4% price improvement, and 5% contribution from acquisitions.

Glanbia’s net debt has been decreased by €144m compared to the end of September 2016, largely due to receiving €210m net cash proceeds relating to the sale of 60% of Dairy Ireland to Glanbia Co-op this year.

The company’s reduced debt position was somewhat offset by the overall €181m spent acquiring US plant nutrition company Amazing Grass and the Dutch direct-to-consumer channel Body & Fit, and increased working capital primarily due to acquisitions, higher activity levels, and higher commodity markets.

Group MD Siobhán Talbot said: “Glanbia delivered a good result in the first nine months of 2017 with wholly owned revenue from continuing operations growing 6.6% in the period. Glanbia Performance Nutrition (GPN) was the main driver of revenue growth with Glanbia Nutritionals (GN) continuing to perform well.

“Our joint ventures delivered strong revenue growth as a result of improved dairy markets. The outlook for the remainder of 2017 is positive and we reiterate our full-year guidance of 7% to 10% growth in pro forma adjusted earnings per share, constant currency, for the continuing group.”

GPN’s nine-month revenues increased by 9%, driven by a 2.7% increase in volume, 7.4% growth from the acquisitions of Amazing Grass, and Body & Fit offset by a 1.1% price decrease.

The overall volume movement this year reflected branded revenue growth offset by a decline in contract business. The drivers of growth have been a good performance in the online and mass channels in the US as well as a strong performance across the EMEA and LAAPAC markets.

GN delivered a good nine-month performance, with revenue growth of 4.6%. This was driven by a price increase of 2.5%, mainly as a result of improved dairy markets, versus prior year and volume growth of 2.1%, driven by Nutritional Solutions.

Stock market commentators and analysts have broadly endorsed the company’s 7%-10% growth forecasts for the year-end.

More in this Section

US rate fears crash party

No surprise if airlines collapse as winter sets in

Little drama and little joy from today’s budget

Breaking Stories

Domino’s trims guidance but sees Irish sales rise

Our political classes ‘quite oblivious’ to risks

Electric Picnic company profits fall 9% to €1.48m

Warning ‘warehoused mortgages’ is next crisis

Breaking Stories

'Jesus, did I paint them?’; Robert Ballagh reacts to the nude portraits to him and his wife

Here's what you can to expect from Making a Murderer 2

’Tis the season... for scares: Your guide to Ireland's Haunted experiences

Ask Audrey: I’m pretending to be a poet to impress a stunning pseudo-intellectual from Clonakilty

More From The Irish Examiner